Market Overview

Piper Jaffray Initiates Coverage on Orexigen Therapeutics, Inc. at Overweight, Announces $10.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for OREX

DateFirmActionFromTo
Mar 2015Leerink SwannMaintainsOutperform
Mar 2015Piper JaffrayMaintainsOverweight
Jan 2015Bank of AmericaMaintainsBuy

View More Analyst Ratings for OREX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (OREX)

Around the Web, We're Loving...